EE53 The Net Monetary Benefit of Introducing Sodium-Glucose Cotransporter-2 Inhibitors in Middle-Income Countries. - Falavigna, M; Deyneli, O; Seyam, A; Mustafa, N; Giorgi, M; Gabriel, Z; Goncalves, S; Solorzano, J; Vasnawala, H; Schabert, V; Mihajlović, J (Value in Health, 2022)